HRP20090190T1 - Pharmaceutical composition comprising a salt of mirtazapine - Google Patents
Pharmaceutical composition comprising a salt of mirtazapineInfo
- Publication number
- HRP20090190T1 HRP20090190T1 HR20090190T HRP20090190T HRP20090190T1 HR P20090190 T1 HRP20090190 T1 HR P20090190T1 HR 20090190 T HR20090190 T HR 20090190T HR P20090190 T HRP20090190 T HR P20090190T HR P20090190 T1 HRP20090190 T1 HR P20090190T1
- Authority
- HR
- Croatia
- Prior art keywords
- salt
- mirtazapine
- pharmaceutical composition
- acid salt
- subliming
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001785 mirtazapine Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101664 | 2004-04-21 | ||
PCT/EP2005/051714 WO2005102352A1 (en) | 2004-04-21 | 2005-04-19 | Pharmaceutical composition comprising a salt of mirtazapine |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090190T1 true HRP20090190T1 (en) | 2009-05-31 |
Family
ID=34928990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090190T HRP20090190T1 (en) | 2004-04-21 | 2009-03-31 | Pharmaceutical composition comprising a salt of mirtazapine |
Country Status (31)
Country | Link |
---|---|
US (1) | US20070111993A1 (sr) |
EP (1) | EP1729777B1 (sr) |
JP (2) | JP5260959B2 (sr) |
CN (2) | CN1942191B (sr) |
AR (1) | AR049028A1 (sr) |
AT (1) | ATE424210T1 (sr) |
AU (1) | AU2005235383B2 (sr) |
BR (1) | BRPI0509953A (sr) |
CA (1) | CA2561281C (sr) |
CY (1) | CY1109018T1 (sr) |
DE (1) | DE602005013066D1 (sr) |
DK (1) | DK1729777T3 (sr) |
EC (1) | ECSP066938A (sr) |
ES (1) | ES2321961T3 (sr) |
HR (1) | HRP20090190T1 (sr) |
IL (1) | IL178201A (sr) |
LV (1) | LV13556B (sr) |
MX (1) | MXPA06011830A (sr) |
MY (1) | MY144899A (sr) |
NO (1) | NO20065077L (sr) |
NZ (1) | NZ550052A (sr) |
PE (1) | PE20060400A1 (sr) |
PL (1) | PL1729777T3 (sr) |
PT (1) | PT1729777E (sr) |
RS (1) | RS50764B (sr) |
RU (1) | RU2375362C2 (sr) |
SI (1) | SI1729777T1 (sr) |
TW (1) | TW200538100A (sr) |
UA (1) | UA89773C2 (sr) |
WO (1) | WO2005102352A1 (sr) |
ZA (1) | ZA200608305B (sr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
CN104095824B (zh) * | 2013-04-09 | 2016-08-31 | 上海信谊万象药业股份有限公司 | 一种米氮平缓释片及其制备方法 |
US10603272B2 (en) | 2015-02-27 | 2020-03-31 | Kindred Biosciences, Inc. | Stimulation of appetite and treatment of anorexia in dogs and cats |
CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US4193828A (en) * | 1976-07-27 | 1980-03-18 | Fiber Materials, Inc. | Method of forming carbon composites |
US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
ATE254918T1 (de) * | 1998-04-02 | 2003-12-15 | Akzo Nobel Nv | Orale flüssige lösung enthaltend das antidepressivum mirtazapine |
WO2001000196A2 (en) * | 1999-06-25 | 2001-01-04 | University Of South Florida | Mirtazapine for weight gain in wasting diseases |
US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
WO2001042239A1 (fr) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
SK14162002A3 (sk) * | 2000-04-05 | 2003-03-04 | Akzo Nobel N.V. | Kombinácia obsahujúca paracetamol alebo nesteroidné protizápalové liečivo, použitie mirtazapínu, paracetamolu a pacientský balíček |
-
2005
- 2005-04-12 TW TW094111559A patent/TW200538100A/zh unknown
- 2005-04-19 UA UAA200610312A patent/UA89773C2/ru unknown
- 2005-04-19 US US11/547,152 patent/US20070111993A1/en not_active Abandoned
- 2005-04-19 MY MYPI20051731A patent/MY144899A/en unknown
- 2005-04-19 CN CN2005800116628A patent/CN1942191B/zh not_active Expired - Fee Related
- 2005-04-19 AT AT05740221T patent/ATE424210T1/de active
- 2005-04-19 MX MXPA06011830A patent/MXPA06011830A/es not_active IP Right Cessation
- 2005-04-19 RS RSP-2009/0164A patent/RS50764B/sr unknown
- 2005-04-19 PT PT05740221T patent/PT1729777E/pt unknown
- 2005-04-19 NZ NZ550052A patent/NZ550052A/en unknown
- 2005-04-19 CN CN201010174000A patent/CN101824035A/zh active Pending
- 2005-04-19 DK DK05740221T patent/DK1729777T3/da active
- 2005-04-19 SI SI200530673T patent/SI1729777T1/sl unknown
- 2005-04-19 BR BRPI0509953-6A patent/BRPI0509953A/pt not_active IP Right Cessation
- 2005-04-19 RU RU2006140988/04A patent/RU2375362C2/ru not_active IP Right Cessation
- 2005-04-19 JP JP2007508904A patent/JP5260959B2/ja not_active Expired - Fee Related
- 2005-04-19 AU AU2005235383A patent/AU2005235383B2/en active Active
- 2005-04-19 ES ES05740221T patent/ES2321961T3/es active Active
- 2005-04-19 EP EP05740221A patent/EP1729777B1/en active Active
- 2005-04-19 CA CA2561281A patent/CA2561281C/en not_active Expired - Fee Related
- 2005-04-19 DE DE602005013066T patent/DE602005013066D1/de active Active
- 2005-04-19 PL PL05740221T patent/PL1729777T3/pl unknown
- 2005-04-19 WO PCT/EP2005/051714 patent/WO2005102352A1/en active Application Filing
- 2005-04-20 PE PE2005000439A patent/PE20060400A1/es not_active Application Discontinuation
- 2005-04-20 AR ARP050101549A patent/AR049028A1/es unknown
-
2006
- 2006-09-20 IL IL178201A patent/IL178201A/en not_active IP Right Cessation
- 2006-10-05 ZA ZA200608305A patent/ZA200608305B/xx unknown
- 2006-10-19 EC EC2006006938A patent/ECSP066938A/es unknown
- 2006-11-03 NO NO20065077A patent/NO20065077L/no not_active Application Discontinuation
- 2006-11-21 LV LVP-06-130A patent/LV13556B/lv unknown
-
2009
- 2009-03-31 HR HR20090190T patent/HRP20090190T1/xx unknown
- 2009-05-05 CY CY20091100481T patent/CY1109018T1/el unknown
-
2013
- 2013-03-08 JP JP2013046645A patent/JP2013136626A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2020010I1 (no) | fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat | |
CY1120138T1 (el) | Στερεη φαρμακευτικη μορφη δοσολογιας που περιλαμβανει μια στερεη διασπορα αναστολεα πρωτεασης toy hiv | |
HRP20080027T3 (en) | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide | |
HRP20090190T1 (en) | Pharmaceutical composition comprising a salt of mirtazapine | |
RS51516B (sr) | Dodatna heterociklična jedinjenja i njihovo korišćenje kao antagonista metabotropnih receptora glutamata | |
RS53371B (sr) | Metod upotrebe sastava aminopiridina sa odloženim oslobađanjem | |
HRP20010573B1 (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
HRP20060240T3 (en) | Intranasal formulation of rotigotine | |
HRP20020158B1 (en) | Action of synergistic combination | |
MY142444A (en) | Chemokine receptor antagonists | |
IT1362675B (it) | N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche | |
WO2006035417A3 (en) | Dihydropyrimidine microcapsule - formulations | |
RS51271B (sr) | Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid | |
RS52891B (sr) | Gastrorezistentne farmaceutske formulacije koje sadrže rifaksimin | |
TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
GEP20104878B (en) | Inhibitors of microsomal triglyceride transfer protein and apo-b secretion | |
DE60100186D1 (de) | Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung | |
NO20043913L (no) | Blandinger med modifisert frigjoring av i det minste en form av tramadol | |
BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
WO2003101996A8 (en) | Esters in position 20 of camptothecins | |
HRP20050055B1 (hr) | Mikrokapsule za odloženo i kontrolirano oslobađanje perindoprila | |
CY2011018I1 (el) | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος | |
RS50722B (sr) | 2-okso-1,2,4,5-tetrahidro-1,3-benzdiazepin-3-il-piperidini korišćeni u vidu cgrp antagonista | |
WO2003037916A3 (en) | Linear basic compounds having nk-2 antagonist activity and formulations thereof |